The Solvency II reform wish list

How should the EU regulation be changed to encourage economic growth, remove unnecessary burdens, inconsistencies and unintended consequences? InsuranceERM analyses the responses to the Commission's call for evidence


Germany hits the brakes on its €32bn ZZR

The ballooning level of additional interest rate reserves has prompted reforms to the rules, but few insurers took advantage in 2015. Hugo Coelho reports


Climate change and geo-economics: the global risks demanding ERM focus

The latest World Economic Forum risks report provides useful indicators for CROs about the changing risk landscape. Asa Gibson reports


Nordea's Annette Olesen: "It feels good to move beyond the go-live date"

The group chief risk officer for Nordea Life & Pensions talks to Christopher Cundy about her company's entry into the Solvency II world


Dear Shareholders...

InsuranceERM imagines what the chairperson of a UK-based composite insurer might be telling its shareholders in 2018 about the evolution of Solvency II and other possible changes in prudential regulation


What to expect in 2016?

Solvency II comes into force today, but it will take a long time before firms enter a business-as-usual environment


Solvency II spreads its tentacles

Solvency II took longer than expected to be implemented in Europe, but what effect has that had on other risk-based capital initiatives across the globe? Asa Gibson reports


ESRB's Mazzaferro: "We want to counter the narrative that insurers are not systemic"

ESRB's head of secretariat makes the case for a countercyclical capital requirement and a liquidity requirement for insurers. Hugo Coelho reports


Living up to the promise of internal models

Supervisory approval is not the end of the Solvency II internal model process. From 1 January, models are for insurers to leverage and for insurers to lose. Hugo Coelho and Christopher Cundy report


Life insurers stuck with the riddle of the risk margin

Of all the innovations of Solvency II, the risk margin threatens to be the most painful for UK life insurers. The transitional benefit will provide relief against it on 1 January, but in the long run it may do more harm than good. Hugo Coelho reports